Fabulous plenary from Dr. Pedram Razavi #sabcs2024 on robust and innovative ai models to separate cdk4/6i responders from non-responders.

Fantastic ER+ #bcsm summary and algorithm by Dr. Danso at year in review. First line CDK 2nd line profile driven ADC/chemo once endo-R! @sabcs.bsky.social #SABCS24 @oncoalert.bsky.social

Congratulations to @reikudo.bsky.social for the beautiful work inspiring current+future studies! #SABCS24

So honored to have gotten the opportunity to present our work showing a prevalent role of APOBEC3 mutagenesis in driving therapy resistance in breast cancer at #SABCS24!

I still remember when @saratchandarlapaty.bsky.social & team discover ESR1 mutations in breast cancer by painstakingly analyzing patient samples and building lab models. Over a decade later, SERDs like imlunestrant show clear survival benefits in this population. Follow the science. #sabcs24

Congratulations to @caiy0219.bsky.social for an excellent poster presentation today! 👏🏽 Also, so happy to be reunited with @reikudo.bsky.social to represent the translational team in @saratchandarlapaty.bsky.social’s lab at #SABCS2024!

OncoAlert & @sabcs.bsky.social 🚨Announce Special Collaboration to Deliver Top #SABCS24 #BreastCancer News Covering all Platforms Linkedin: https://buff.ly/4f37sDT X: https://buff.ly/49iPrjV Facebook: https://buff.ly/4g5qquK Instagram: https://buff.ly/49lquV8 Threads: https://buff.ly/3B7ZHih

I also LOVE rational therapeutics.